Core Scientific, Inc./tx Quarterly Debt-to-equity in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Core Scientific, Inc./tx quarterly Debt-to-equity history and growth rate from Q3 2021 to Q2 2024.
  • Core Scientific, Inc./tx Debt-to-equity for the quarter ending June 30, 2024 was -224 %, a 48% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 -224 +207 +48% Jun 30, 2024
Q1 2024 -273 +1.35K +83.1% Mar 31, 2024
Q4 2023 -262 -722 -157% Dec 31, 2023
Q3 2023 -287 -469 -257% Sep 30, 2023
Q2 2023 -431 -529 -537% Jun 30, 2023
Q1 2023 -1.62K -1.69K -2393% Mar 31, 2023
Q4 2022 460 +419 +1010% Dec 31, 2022
Q3 2022 182 +175 +2331% Sep 30, 2022
Q2 2022 98.5 Jun 30, 2022
Q1 2022 70.6 Mar 31, 2022
Q4 2021 41.5 Dec 31, 2021
Q3 2021 7.5 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.